biomedicina slovenica


"INTERFERON-ALPHA" : 95

  1. Boc Marko; Ocvirk Janja
    Safety and efficacy of adjuvant high dose IFN- [alpha] -2b treatment in malignant melanoma
    2009
  2. Filipič Bratko; Gradišnik Lidija; Rihar Klemen; Šooš Eugen; Pereyra Gonzales Adriana; Potokar Jana
    The influence of royal jelly and human interferon-alpha (HuIFN-[alpha]N3) on proliferation, glutathione level and lipid peroxidation in human colorectal adenocarcinoma cells in vitro
    [Vpliv matičnega mlečka in humanega interferona-alfa (HuIFN-[alfa]N3) na proliferacijo, nivo glutationa in na preoksidacijo lipidov v humanih kolorektalnih adenokarcinomskih celicah in vitro]
    2015
  3. Filipič Bratko; Potokar Jana
    The influence of royal jelly (RJ) on human interferon-alpha's (HuIFN-AN3) inhibition of human colon cancer cells (CaCo-2) proliferation in vitro
    2014
  4. Filipič Bratko; Gradišnik Lidija; Pereyra Gonzales Adriana; Potokar Jana; Koren Srečko
    The influence of royal jelly (RJ) on human interferon-alpha's (HuIFN-[alpha]N3) inhibition of human colon cancer cells (caCo-2) proliferation In vitro
    2014
  5. Filipič Bratko
    Effect of royal jelly (RJ) on human interferon - alpha (HuIFN-alpha) inhibition of human colon cancer cells (CaCo-2) proliferation in vitro
    2013
  6. Selič Tanja; Lešničar Gorazd; Poljak Mario; Meglič-Volkar Jelka; Rajter Mojca; Prah Janja; Baklan Zvonko; Kotar Tadeja; Matičič Mojca
    Impact of added fluvastatin to standard-of-care treatment on sustained virological response in naïve chronic hepatitis C Patients infected with genotypes 1 and 3
    2013
  7. Poljak Mario; Židovec-Lepej Snježana; Ðaković-Rode Oktavija
    Novosti u serološkoj i molekularnoj dijagnostici hepatitisa B i C
    [Recent developments in serologic and molecular diagnosis of hepatitis B and C]
    2013
  8. Plesničar Andrej; Vidmar Gaj; Štabuc Borut; Kores-Plesničar Blanka
    Effects of recombinant human tumor necrosis factor-alpha and its combination with native human leukocyte interferon-alpha on P3-X63- Ag8.653 mouse myeloma cell growth
    2012
  9. Okeoma Chioma M; Low Audrey; Bailis Will; Fan Hung Y; Peterlin Matija B; Ross Susan R
    Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection
    2009
  10. Plesničar Andrej; Vidmar Gaj; Štabuc Borut; Kores-Plesničar Blanka
    Effects of native human leukocyte interferon-[alpha] and recombinant human interferon-[alpha] on P3-X63-Ag8.653 mouse myeloma cell growth
    2009
  11. Lukić Milica; Terčelj Marjeta; Salobir Barbara
    Pulmonary sarcoidosis induced by interferon-alpha therapy in chronic vilar hepatitis C - a case report
    2009
  12. Goropevšek Aleš; Homšak Evgenija; Gorenjak Maksimiljan; Malešič Ivan; Krajnc Ivan; Cencič Avrelija
    Novejši biooznačevalci in spremljenje znotrajceličnih signalnih poti pri avtoimunskih boleznih
    [New biomarkers and monitoring intracellular signaling pathways in autoimmune diseases]
    2008
  13. Strle Klemen; McCusker Robert H; Tran Lynn; King Alexandra; Johnson Rodney W; Freund Gregory G; Dantzer Robert; Kelley Keith W
    Novel activity of an anti-inflammatory cytokine: IL-10 prevents TNFalpha-induced resistance to IGF-I in myoblasts
    2007
  14. Pukmeister B; Borinc-Beden A
    Hemangiomi obraza in mediastinuma - prikaz primera
    [Facial and mediastinal haemangiomas - case report]
    2007
  15. Smilović Vanja
    Razvoj celične linije za določanje biološke aktivnosti interferonov
    [Development of cell line suitable for the determination of biological activity of interferons]
    2006
  16. Seme Katja; Poljak Mario; Babič Dunja Z; Močilnik Tina; Vince Adriana
    The role of core antigen detection in management of hepatitis C: a critical review
    2005
  17. Ocvirk Janja
    Adjuvantno in paliativno sistemsko zdravljenje malignega melanoma
    2005
  18. Godina-Kariž Stanka; Avancini Nives; Kariž Stojan
    Anteriorna ishemična optična nevropatija kot posledica zdravljenja z interferonom alfa
    [Anterior ischemic optic neuropathy secondary to interferon alpha]
    2005
  19. Lešničar Gorazd
    Zdravljenje bolnikov s kroničnim hepatitisom B v Splošni bolnišnici Celje
    [Treatment of patients with chronic hepatitis B in General hospital Celje]
    2005
  20. Seme Katja; Poljak Mario; Meško Karmen M; Fujs Kristina; Babič Dunja Z; Močilnik Tina
    Microbiological monitoring of chronic viral hepatitis
    2004
  21. Lešničar Gorazd; Poljak Mario; Luzar Boštjan; Ferlan-Marolt Vera; Brinovec Vladimir; Matičič Mojca; Meglič-Volkar Jelka; Baklan Zvonko; Vidmar Ludvik; Seme Katja; Babič Dunja
    Zdravljenje bolnikov s kroničnim hepatitisom B - naše izkušnje
    2004
  22. Matičič M; Meglič-Volkar J; Brinovec V; Lešničar G; Baklan Z; Rajter M; Poljak M; Ferlan-Marolt V; Luzar B
    Treatment of viral hepatitis C
    2004
  23. Zakotnik Breda; Čižman Milan
    Viral hepatitis in childhood
    2004
  24. Hrstić I; Vučelić B; Ostojić R; Rustemović N; Opačić M; Čavka S; Kalauz M; Premužić M; Radić D; Ščukanec M
    Triple combination therapy with interferon alfa, ribavarin and amantadine as a treatment of chronic hepatitis C in relapses or nonresponders to interferon alfa-ribavarin therapy
    2004
  25. Matičič Mojca
    Treatment of chronic hepatitis C in special patients populations
    2004
  26. Markovič Saša
    Management of patients with chronic hepatitis B
    2004
  27. Ferenci P
    Treatment of chronic hepatitis C
    2004
  28. Rogl-Butina Mirjam; Bartenjev Igor
    Nekirurško zdravljenje prekanceroz
    2004
  29. Matičič Mojca
    Novosti v zdravljenju kroničnega hepatitisa C
    [Treatment of chronic hepatitis C: an update]
    2004
  30. Filipič Bratko; Toth Sandor; Sladoljev Srečko; Koren Srečko
    Aminokisline modulirajo biološke aktivnosti HuIFN-alfa na različne načine
    [Amino acids modulate the biological activities of HuIFN-alpha in different ways]
    2004
  31. Fleischmann William Robert; Wu Tzu G
    Development of a vaccine against cancers
    [Razvoj cepiva proti raku]
    2004
  32. Stantić-Pavlinić Mirjana; Banič Stanko; Marin Jožica; Klemenc Polona
    Vitamin C - a challenge in the management of rabies
    2004
  33. Štabuc Borut
    Systemic therapy for colorectal cancer
    2003
  34. Brinovec V; Lešničar G; Meglič-Volkar J; Matičič M; Baklan Z; Poljak M; Seme K; Ferlan-Marolt V; Luzar B
    Treatment of chronic hepatitis C: our experience
    2004
  35. Marin Irena
    Metode za določanje virusnega bremena in njihov pomen v diagnostiki ter spremljanju poteka in zdravljenja hepatitisa B
    [Methods for the measurement of hepatitis B virus DNA loads and their value in diagnostics and monitoring of antiviral treatment of hepatitis B]
    2003
  36. Hafner Matjaž
    Nov pristop k zdravljenju kroničnega hepatitisa C
    2003
  37. Černelč Peter
    Zdravljenje primarne plazmacelične levkemije
    [Treatment of primary plasma cell leukemia]
    2003
  38. Černelč Peter
    Zdravljenje kronične mieloične levkemije z Glivecom
    2002
  39. Hočevar-Boltežar Irena; Žargi Miha
    Laryngeal papillomatosis
    [Papilomatoza grla]
    2002
  40. Pretnar Gorazd; Steindl Franz
    Time dependent cell growth in biomedical research with general cell screening system
    2002
  41. Brinovec V; Lešničar G; Meglič-Volkar J; Matičič M; Baklan Z; Poljak M; Seme K; Ferlan-Marolt V
    Efficacy of chronic hepatitis C therapy with interferon alpha (IFN-alpha) in Slovenia
    2002
  42. Brinovec Vladimir; Lešničar Gorazd; Meglič-Volkar Jelka; Matičič Mojca; Baklan Zvonko; Zafred-Remec Tatjana; Poljak Mario; Seme Katja; Ferlan-Marolt Vera
    Naše izkušnje pri zdravljenju kroničnega hepatitisa C
    [Treatment of chronic hepatitis C: our experiences]
    2001
  43. Marinko Petra; Krbavčič Aleš
    Imunogenost interferona: predklinično in klinično vrednotenje interferona alfa
    [Immunogenicity of interferon: preclinical and clinical evaluation of interferon alpha]
    2001
  44. Marinko Petra; Krbavčič Aleš
    Imunogenost interferona: tehnično vrednotenje interferona alfa
    [Immunogenicity of interferon: technical evaluation of interferon alpha]
    2001
  45. Zver Samo
    Sistemska mastocitoza
    [Systemic mastocytosis]
    2001
  46. Fleischmann W Robert Jr; Koren Srečko
    Systemic effects of orally administered interferons and interleukin-2
    1999
  47. Glaser Marjan
    Naše izkušnje zdravljenja z interferonom alfa pri mlajših bolnikih z esencialno trombocitemijo
    [Our experience with interferon alpha therapy in younger patients with essential thrombocytaemia]
    2000
  48. Remškar Zlata; Mlinarič Vladimir; Lešničar Gorazd
    Sarkoidoza ob zdravljenju kroničnega hepatitisa C z interferonom alfa - prikaz primera
    [Sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha - case report]
    1999
  49. Rudolf Zvonimir
    Adjuvantno zdravljenje malignega melanoma
    [Adjuvant treatment of malignant melanoma]
    1999
  50. Hafner Matjaž
    Terapija kroničnega hepatitisa
    1999
  51. Stanovnik M; Čufer T; Borštnar S; Pajk B
    Clinical study with interferon alpha-2A and cis-retinoic acid (CRA) in metastatic cancer of the kidney
    1998
  52. Jereb Berta
    Zdravljenje bolnikov s plevralno karcinozo pri nemikrocelularnem (NMCCP) karcinomu s humanim interferonom alfa (INFA-alfa)
    1998
  53. Lake John R
    Treatment of chronic viral hepatitis
    1998
  54. Bren Andrej F; Kandus Aljoša; Ferluga Dušan
    Interferon-alpha associated rapidly progressive renal graft failure in patient with chronic myelogenaus leukemia
    1998
  55. Bren A; Kandus A; Ferluga D
    Rapidly progressive renal graft failure associated with interferon-alpha treatment in a patient with chronic myelogenous leukemia
    1998
  56. Filipič B; Koren S; Orešić K; Mecs I; Toth S; Kovacs K
    Antiproliferativna in citotoksična aktivnost humanega levkocitnega interferona in njegovih podtipov
    [Antiproliferative and cytotoxic activity of human leukocyte interferon and its subtypes]
    1998
  57. Strojan P; Rudolf Z
    Immunochemotherapy with recombinant interferon-alpha2b plus dacarbazine in the treatment of advanced malignant melanoma
    1997
  58. Filipič B; Toth S; Koren S; Kovasc K
    The priming effect of human and porcine interferon-alpha on sendai virus induction of IFN production in adult PIG kindey (PLA) cells in vitro
    1997
  59. Kitak Nataša; Miklavčič Damijan; Serša Gregor
    Protitumorski učinki elektroterapije v kombinaciji z modifikatorji biološkega odziva
    [Anti-tumor effects of electrotherapy combined with biological response modifieres]
    1997
  60. Jereb Berta
    Interferon alpha (IFN-alpha) in treatment of malignant diseases
    1997
  61. Denišlič M; Šega-Jazbec S
    Zdravljenje multiple skleroze
    1996
  62. Brinovec V
    Zdravljenje hepatitisa B in C
    [Treatment of hepatitis B and C]
    1995
  63. Štalc A
    Pregled v zdravljenje uvedenih rekombinantnih zdravil
    [A review of recombinant drugs introduced into the therapy]
    1996
  64. Rudolf Z; Strojan P
    DTIC vs. IFN-alpha plus DTIC in the treatment of patients with metastatic malignant melanoma
    1996
  65. Černelč Peter; Mlakar Uroš
    Prava policitemija
    1995
  66. Mlakar U
    Vzdrževalno zdravljenje dlakastocelične levkemije z interferonom alfa
    [Maintenance treatment of hairy cell leukemia with interferon alpha]
    1995
  67. Koren S; Fleischmann WR Jr
    Sistemsko učinkovanje oralno apliciranih citokinov
    [Systemic effects of orally administered cytokines]
    1995
  68. Eberl-Gregorič E; Filipič B
    Vpliv humanega alfa interferona na okužbo celic z bakterijo Legionella pneumophila
    [The influence of human alpha interferon on cell infection with bacteria Legionella pneumophila]
    1995
  69. Serša G; Willingham V; Milas L
    Augumentation of tumor necrosis factor alpha cytotoxicity by interferon alpha
    1990
  70. Filipič B; Rozman S; Carlsson K; Cencič A
    Porcine interferon gamma (PoIFN Gamma)
    [Prašičji interferon gama (PoIFN Gamma)]
    1994
  71. Koren S; Fleischmann WR Jr
    Chronobiology of the interferon system
    [Kronobiologija interferonskega sistema]
    1994
  72. Fleischmann CM
    Tumor studies using tumor cells resistant to interferon
    [Odpornost tumorskih celic za interferon]
    1994
  73. Jereb B; Petrič-Grabnar G; Klun B; Lamovec J; Škrbec M; Soos E
    Addition of IFN-alpha to treatment of malignant brain tumors
    1994
  74. Filipič B; Golob A; Struna T; Likar M
    Porcine mitogen-induced interferon
    1994
  75. Fleischmann WR Jr; Koren S
    The use of combination therapies to enhance interferon action
    1987
  76. Koren S; Fleischmann WR Jr
    Orally administered interferons suppress bone marrow function (43646)
    1993
  77. Duc-Goiran P; Robert B; Navarro S; Lopez J; Chavinie J; Ferre F; Chany C; Doly J
    Type I interferons spontaneously expressed during human pregnancy
    1993
  78. Jezeršek B
    Interakcije interferona in vinblastina na eksperimentalnem tumorskem modelu melanoma B-16 in vitro ter in vivo
    1994
  79. Štabuc B
    Anti-tumor effect of interferon alpha in combination with cisplatin - animal experiments
    1993
  80. Novaković S; Fleischmann WR Jr
    Antitumor effect on interferon-alpha administered by different routes of treatment
    1993
  81. Serša G; Miklavčič D
    Combined treatment of murine SA-1 tumors by human leukocyte interferon alpha and electrotherapy
    1993
  82. Jezeršek B; Novaković S; Serša G; Čemažar M; Auersperg M; Fleischmann WR Jr
    Interactions of interferon and vinblastine on experimental tumor model melanoma B-16 in vivo
    1993
  83. Rudolf Z
    Adjuvant treatment of malignant melanoma with interferon after radical surgery - part II: effect of recombinant alpha interferon
    1994
  84. Jezeršek B; Novaković S; Serša G; Auersperg M; Fleischmann WR Jr
    Interactions of interferon and vinblastine on experimental tumor model melanoma B-16 in vitro
    1994
  85. Černelč P; Mlakar U
    Zdravljenje primarne plazmacelične levkemije z interferonom alfa
    [Treatment of primary plasma cell leukemia with interferon alfa]
    1994
  86. Jereb Berta; Petrič-Grabnar Gabrijela; Terčelj-Zorman Marjeta; Us-Krašovec Marija; Mažuran Renata; Šooš Evgen; Stare Janez
    Natural IFN-alpha for non-small-cell lung cancer with pleural carcinosis
    1993
  87. Singer Z; Šooš E; Feichter G
    Treatment of cervical intraepithelial neoplasia associated with human pappilomavirus by interferon vaginalettes
    1993
  88. Palmović D; Crnjaković-Palmović J
    Alpha interferon in the treatment of chronic hepatitis C
    1993
  89. Eberl-Gregorič E
    Vpliv humanih in humanim podobnih interferonov na bakterijo Legionella pneumophila
    1993
  90. Klun B; Jereb B; Petrič J; Tekavčič I; Popadić A
    Intratumoral administration of interferon-alpha in malignant gliomas
    1992
  91. Štabuc B
    Imunopotenciacija s citotoksičnimi zdravili in interferonom alfa pri bolnikih z melanomom
    1993
  92. Koren S; Fleischmann WR Jr
    Circadian variations in myelosuppressive activity of interferon-alpha in mice: identification of an optimal treatment time associated with reduced myelosuppressive activity
    1993
  93. Kotnik V; Fleischmann WR Jr
    IFN alpha/beta, IFN gamma, TNF alpha and combinations of IFN gamma/TNF alpha as C57B1/6 mice bone marrow cells proliferation inhibitors and differentiation factors
    1990
  94. Terčelj-Zorman M; Mermolja M; Jereb M; Oman M; Šooš E; Petrič-Grabnar G; Jereb B
    Human leukocyte interferon alpha (HLI-alpha) for treatment of pleural effusion caused by non small cell lung cancer: a pilot study
    1991
  95. Jereb B; Petrič J; Lamovec J; Škrbec M; Šošš E
    Intratumor application of human leukocyte interferon-alpha in patients with malignant brain tumors
    1989



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics